In this paper, we provide evidence for a pathway of acetylation-mediated nucleosome remodeling and eviction in transcribed coding sequences that stimulates elongation by Pol II in vivo. We obtained several lines of evidence that H3 acetylation by SAGA and H4 acetylation by NuA4 both contribute to efficient elongation in vivo. Thus,
esa1 and
gcn5Δ each confer sensitivity to 6-AU and provoke gene length-dependent defects in transcription, and these phenotypes are exacerbated in a double mutant impaired for both KATs. Using an in vivo assay to measure the rate of Pol II elongation, we found that
esa1 reduces the rate of elongation and exacerbates a smaller reduction in elongation rate in
gcn5Δ cells. Mutations in numerous elongation factors have been examined with this assay, including Paf1C subunits, Spt4, TFIIS, THO/TREX subunits, CTK1, and SWI/SNF, but none reduced the Pol II elongation rate (
32). Thus, apart from a mutation in Rpb1 of Pol II itself, these are the first mutations described in yeast that appear to reduce the elongation rate in vivo. It is possible that the effects of the
esa1 mutation on transcription elongation involve impaired recruitment of SAGA. However, the fact that
esa1 exacerbates the transcription elongation defects observed in
gcn5Δ cells (lacking the SAGA KAT) indicates that NuA4 and SAGA KAT activities contribute independently to transcription elongation. Consistent with this conclusion, we found that eliminating Gcn5 does not impair recruitment of NuA4 to Gcn4 target genes (data not shown).
Because nucleosomes impede Pol II elongation and are evicted during transcription, mutations in chromatin modifying factors might be expected to reduce the elongation rate by reducing nucleosome disassembly (
32). Indeed, we made the novel finding that loss of H4 acetylation in
esa1, in addition to loss of H3 acetylation in
gcn5Δ, dampens nucleosome eviction from the
GAL1 ORF during transcription. Histone acetylation could stimulate nucleosome eviction by weakening histone-DNA interactions or creating a binding surface for BD-containing chromatin remodeling complexes. Previous genome-wide localization of RSC identified primarily Pol II promoters and Pol III genes as binding sites (
14,
37). However, we found that RSC occupancies at
GAL1 are substantially higher in the ORF versus UAS. While this work was in progress, RSC was shown to be recruited exclusively to the coding sequences of stress-induced genes regulated by mitogen-activated protein kinase Hog1 (
31). Hence, ORF association by RSC could be a characteristic of highly inducible genes. SWI/SNF has also been shown to occupy coding sequences and affect Pol II occupancy in the ORF (
20,
52), but the role of histone acetylation in its cotranscriptional recruitment was unknown.
We found that recruitment of RSC and SWI/SNF to the coding regions of
GAL1 was enhanced to varying degrees by H3 and H4 acetylation by Gcn5 and Esa1. These results provide in vivo evidence supporting the idea that acetylated nucleosomes provide an optimal substrate for cotranscriptional recruitment of RSC and SWI/SNF via their BD-containing subunits. Previous work showed that Rsc4 tandem BDs bind H3 tail peptides acetylated on Lys14 and suggested that H3-Lys14 acetylation by Gcn5 is more critical than H4 acetylation by Esa1 for nucleosome binding of Rsc4 BDs (
26). It could be that BDs in other RSC subunits are more dependent on acetylated H4 to explain the strong effects of
esa1 on RSC recruitment to
GAL1 observed here. Indeed, SAGA and NuA4 both stimulate RSC recruitment to a nucleosomal template in vitro (
9). The association of RSC with coding sequences might also be enhanced by direct association of RSC with elongating Pol II via Rsc4 interaction with Rpb5 (
56).
Consistent with our finding of RSC recruitment to coding sequences, we observed phenotypes indicating elongation defects in strains lacking the Rsc1- or Rsc2-containing forms of these complexes, including increased sensitivity to 6AU and gene length-dependent defects in transcript accumulation. Interestingly, mutational inactivation of RSC subunit Rsc9 appeared to diminish the progression of elongating Pol II through the 3′ end of the
STL1 ORF, a stress-induced gene with high RSC occupancy of coding sequences, providing further evidence that RSC can stimulate elongation in vivo (
31). The
esa1 and
rsc2Δ mutations produced nonadditive phenotypes in the gene-length dependent reporter assays, consistent with the possibility that Esa1 stimulates elongation by promoting RSC recruitment or function. However, we have not detected a decreased rate of Pol II elongation in the
PGAL1-YLR454w ORF after promoter shutoff in
rsc1Δ or
rsc2Δ mutants (data not shown). This implies that the effect of
esa1 in reducing the elongation rate does not arise simply from impaired RSC recruitment, although it must be recalled that none of these mutations eliminates RSC function. We did observe a small decrease in Pol II occupancy toward the 3′ end of the 8-kb
PGAL1-YLR454w ORF under inducing conditions in
rsc2Δ cells (Fig. ), suggesting a decrease in Pol II processivity (
32). Like
rsc2Δ, mutations in several elongation factors were shown previously to impair processivity without decreasing elongation rate (
32). To explain the gene length-dependent reductions in transcription observed in
rsc1Δ and
rsc2Δ cells, it might be necessary to posit defects in another aspect of mRNA biogenesis during elongation in addition to Pol II processivity, such as cotranscriptional mRNP assembly.
Several studies showed that Esa1 and Epl1 are recruited to UASs, but it was unclear whether this occurs in the context of NuA4, picNuA4, or both. By ChIP analysis of Eaf1 (unique to NuA4), we provided direct evidence that NuA4 is recruited to UASs by Gal4 and Gcn4. Our unexpected findings that
eaf1Δ does not completely disrupt NuA4 but impairs association of Tra1 with the rest of the complex, and also reduces NuA4 recruitment to the UAS, provide in vivo evidence for the importance of Tra1 in NuA4 recruitment by an activator. The finding in other studies that NuA4 was completely disrupted in
eaf1Δ extracts (
3,
33) might be explained by the fact that our coimmunoprecipitation assay involves rapid, small-scale affinity purification without an elution step, perhaps allowing us to preserve a labile, incompletely disrupted NuA4 complex.
Previous ChIP studies suggested that Esa1 and Epl1 are restricted to promoters (
46,
48). Motivated by our findings that Esa1 stimulates elongation, we provided the first evidence that NuA4 subunits (including Eaf1) occupy the coding sequences of both constitutive and inducible genes at levels comparable to their corresponding UAS occupancies. It could be argued that gene looping, wherein the 5′ end 3′ ends of the gene are physically connected (
2), contributes to NuA4 occupancy of coding sequences; however, our data suggest that this contribution is either small or nonexistent. First, we found that NuA4 occupancy is detected across the
ARG1 ORF and is not limited to only the 5′ and 3′ ends (Fig. ). Second, we were unable to detect the activator Gcn4 in coding sequences (data not shown), indicating that not all promoter-bound factors are detected in the ORF by our ChIP protocol. Most importantly, we found that disruption of NuA4 promoter occupancy in
eaf1Δ does not affect its ORF occupancy (Fig. ). Taken together, these data suggest that NuA4 is recruited to coding sequences independent of gene looping, as we showed previously for SAGA (
21).
We also established that the ORF association of NuA4 occurs cotranscriptionally and is stimulated by Ser5 CTD phosphorylation by Kin28, and we further demonstrated that NuA4 is associated in vivo with Rpb1 phosphorylated on Ser5 or Ser2, which represent elongating forms of Pol II. NuA4 also coimmunoprecipitated with hypophosphorylated Rpb1, which should represent Pol II at the promoter. We suggest that NuA4 interacts with Pol II at the promoter in a manner enhanced by its association with activators or coactivators bound to the UAS. Lacking these interactions in the coding sequences, NuA4's interaction with elongating Pol II would be enhanced by the phosphorylated CTD.
Recruitment of NuA4 to coding sequences has been suspected because it contains three subunits harboring chromodomains or PHD fingers, and H3 methylation by Set1 and Set2 occurs cotranscriptionally. Surprisingly, we found that eliminating both Set1 and Set2 produces little or no reduction in NuA4 occupancy of coding sequences at several different genes and only a moderate reduction in H4 acetylation at
ARG1, as assayed by ChIP (Fig. ). Furthermore,
set1Δ set2Δ had no effect on NuA4's association with bulk elongating Pol II phosphorylated on Ser2 of the CTD in coimmunoprecipitation assays (Fig. ). By contrast, H3 methylation by Set1 or Set2 was required for measurable coimmunoprecipitation of NuA4 with H3 (Fig. ). One way to account for these findings is to propose that elimination of Set1 and Set2 does not abolish NuA4-H3 association, but it increases the off rate of the interaction in a manner that reduces H4 acetylation by NuA4. This last defect would be partially offset by impaired recruitment of the histone deacetylase complexes Set3C and Rpd3-S, which also depends on H3 methylation by Set1 or Set2, respectively (
10,
27,
28). This scenario can account for the observed stronger reduction in NuA4-H3 association observed in our coimmunoprecipitation assays, which involve extensive washing of immune complexes, compared to ChIP assays, where interactions are preserved by cross-linking. However, our finding that
set1Δ
set2Δ has no detectable effect on association of NuA4 with elongating Pol II leads us to suggest a two-step mechanism for cotranscriptional association of NuA4 with nucleosomes, wherein NuA4 is recruited to sites of transcription by the phosphorylated Pol II CTD and then binds to nucleosomes containing methylated H3 tails to facilitate H4 acetylation (Fig. ). This in turn weakens histone-DNA contacts and promotes recruitment of RSC and SWI/SNF through their BDs, the combination of which facilitates nucleosome eviction and enhances the rate of transcription elongation in vivo.